Sign in

CIK 0001628171 · Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472029180
Phone
650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$85,328,124
in 21 filings, $85.3M under 10b5-1 plans

Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. GOLDSMITH MARK A −$20.8M See Remarks sold 28% of stake
  2. Kelsey Stephen Michael −$19.8M See Remarks sold 26% of stake
  3. Kim Lorence H. −$15.0M Director sold 100% of stake
  4. Cislini Jeff −$12.7M SVP & General Counsel sold 54% of stake
  5. Anders Jack −$7.5M Chief Financial Officer sold 25% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-09-24 Cislini Jeff General Counsel Sale 10b5-1 −1,799 $44.26 $80K 50,425
2025-09-16 Wei Lin Chief Medical Officer Sale 10b5-1 −2,160 $45.82 $99K 88,339
2025-09-16 Kelsey Stephen Michael See Remarks Sale 10b5-1 −5,367 $45.82 $246K 284,047
2025-09-16 GOLDSMITH MARK A See Remarks Sale 10b5-1 −13,411 $45.82 $615K 452,309
2025-09-16 Horn Margaret A Chief Operating Officer Sale 10b5-1 −4,775 $45.82 $219K 145,900
2025-09-16 Cislini Jeff General Counsel Sale 10b5-1 −1,869 $45.82 $86K 52,224
2025-09-16 Anders Jack Chief Financial Officer Sale 10b5-1 −2,320 $45.82 $106K 110,994
2025-09-15 Kelsey Stephen Michael See Remarks Option exercise 10b5-1 +25,000 $4.73 $118K 314,414
2025-09-15 Kelsey Stephen Michael See Remarks Sale 10b5-1 −23,682 $45.92 $1.1M 290,732
2025-09-15 Kelsey Stephen Michael See Remarks Sale 10b5-1 −1,318 $46.93 $62K 289,414
2025-09-15 Kelsey Stephen Michael See Remarks Option exercise · Stock Option (Right to Buy) 10b5-1 −25,000 30,055
2025-09-11 Kelsey Stephen Michael See Remarks Option exercise 10b5-1 +100,000 $4.73 $473K 389,414
2025-09-11 Kelsey Stephen Michael See Remarks Sale 10b5-1 −44,059 $43.58 $1.9M 345,355
2025-09-11 Kelsey Stephen Michael See Remarks Sale 10b5-1 −55,941 $44.48 $2.5M 289,414
2025-09-11 Kelsey Stephen Michael See Remarks Option exercise · Stock Option (Right to Buy) 10b5-1 −100,000 55,055
2025-09-03 Anders Jack Chief Financial Officer Option exercise 10b5-1 +3,189 $4.73 $15K 116,503
2025-09-03 Anders Jack Chief Financial Officer Option exercise 10b5-1 +2,049 $17.00 $35K 118,552
2025-09-03 Anders Jack Chief Financial Officer Sale 10b5-1 −5,238 $40.17 $210K 113,314
2025-09-03 Anders Jack Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −3,189 0
2025-09-03 Anders Jack Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −2,049 15,418

Page 16 of 18 · 352 trades